What genetic risk factors predispose individuals to developing CTE following repetitive brain trauma?

PARTIALLY ADDRESSED

The abstract explicitly states the critical need to identify genetic risk factors for CTE, but these remain unknown. Understanding genetic susceptibility could enable risk stratification and personalized prevention strategies for athletes and military personnel. Gap type: open_question Source paper: The neuropathology of chronic traumatic encephalopathy. (2015, Brain pathology (Zurich, Switzerland), PMID:25904048)

Priority: 0.89 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What genetic risk factors predispose individuals to developing CTE following repetitive brain trauma? is a 0.89 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What genetic risk factors predispose individuals to developing CTE following repetitive brain trauma? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

associated with (1)

microglial dysfunctionCTE

co associated with (1)

APOECTE

phosphorylates (1)

CTETAU
🕑 Activity Feed
update on knowledge_gap by max_outlook1 2026-04-28T01:37
update on knowledge_gap by None 2026-04-25T22:15
update on knowledge_gap by None 2026-04-14T19:12
update on knowledge_gap by None 2026-04-14T19:12
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps